Syndax Pharmaceuticals, Inc. Share Price
SNDXSyndax Pharmaceuticals, Inc. Stock Performance
Open $15.33 | Prev. Close $15.04 | Circuit Range N/A |
Day Range $14.87 - $15.81 | Year Range $8.58 - $22.50 | Volume 80,841 |
Average Traded $15.45 |
Syndax Pharmaceuticals, Inc. Share Price Chart
About Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory (R/R) acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.
Syndax Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
26-Sep-25 | $15.33 | $15.67 | +4.26% |
25-Sep-25 | $15.03 | $15.03 | +0.13% |
24-Sep-25 | $14.88 | $15.01 | +1.11% |
23-Sep-25 | $14.77 | $14.85 | -0.17% |
22-Sep-25 | $14.89 | $14.87 | +0.75% |
19-Sep-25 | $15.63 | $14.76 | -4.34% |
18-Sep-25 | $15.02 | $15.43 | +4.61% |
FAQs on Syndax Pharmaceuticals, Inc. Share Price
Can I buy Syndax Pharmaceuticals, Inc. shares in India?
What is the share price of Syndax Pharmaceuticals, Inc.?
What is the 5 year returns of Syndax Pharmaceuticals, Inc.?
What are the high & low stock price of Syndax Pharmaceuticals, Inc. today?
What is the 52-week high and low of Syndax Pharmaceuticals, Inc. stock?